Pfizer Picking Up FoldRx in Latest Rare Disease Buyout
Just days after Sanofi-Aventis SA's official bid for Genzyme Corp., big pharma's pursuit of orphan drugs continued with Pfizer Inc.'s plan to buy out privately held FoldRx Pharmaceuticals Inc. for rights to a drug for rare neurodegenerative disease transthyretin amyloid polyneuropathy (ATTR-PN).
Read more...
Drug Companies Hunt for Alternatives to Steroids
Drug makers are trying to develop medicines that possess the muscle-building ability of testosterone without its side effects.
Read more...
Doctors seek to slow loss of muscle tone among aging
Why muscles wither with age is captivating a growing number of scientists and others.
Read more...
Steroids ban must be for life
The benefits of using steroids can last a lifetime, according to a recent study.
Read more...
Smoking marijuana helps reduce pain, trial shows
Researchers in Montreal have completed what they say is the first placebo-controlled clinical trial to show that smoking pot really helps to relieve pain.
Read more...
Blogsphere:
Technorati
Feedster
Bloglines
Bookmark:
Del.icio.us
Spurl
Furl
Simpy
Blink
Digg